Cardinal Health, Inc. (NYSE:CAH) Receives $140.14 Consensus PT from Brokerages

Cardinal Health, Inc. (NYSE:CAH) has been given a consensus recommendation of “Moderate Buy” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $140.86.

A number of equities analysts recently weighed in on the company. Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Citigroup raised their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Jefferies Financial Group upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Finally, Mizuho lifted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Monday, March 31st.

Cardinal Health Trading Up 2.1 %

NYSE:CAH opened at $131.65 on Monday. The company has a 50-day moving average of $129.33 and a 200-day moving average of $122.39. The firm has a market cap of $31.80 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. Cardinal Health has a twelve month low of $93.17 and a twelve month high of $139.50.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts forecast that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Institutional Investors Weigh In On Cardinal Health

Several institutional investors and hedge funds have recently modified their holdings of CAH. Cyrus J. Lawrence LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth about $26,000. Promus Capital LLC bought a new stake in Cardinal Health during the fourth quarter worth approximately $30,000. Bellwether Advisors LLC bought a new position in shares of Cardinal Health in the fourth quarter valued at approximately $32,000. Tompkins Financial Corp raised its position in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after purchasing an additional 128 shares during the period. Finally, Lee Danner & Bass Inc. acquired a new stake in shares of Cardinal Health in the fourth quarter worth $35,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.